DanielARossignolMD

PubMed

• 1 citations
  Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment.
  Harumi Jyonouchi, Lee Geng, Daniel A Rossignol, Richard E Frye> ;Journal of Personalized Medicine. 2022 Nov 2
• Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Dis...
  Daniel A Rossignol, Richard E Frye> ;Journal of Personalized Medicine. 2022 Apr 29
• A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder.
  Richard E Frye, Shannon Rose, Richard G Boles, Daniel A Rossignol> ;Journal of Personalized Medicine. 2022 Jan 24
• 26 citations
  Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Ana...
  Daniel A. Rossignol, Richard E. Frye> ;Journal of Personalized Medicine. 2021 Nov 3
• 6 citations
  Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey.
  James B. Adams, Anisha Bhargava, Devon M. Coleman, Richard E. Frye, Daniel A. Rossignol> ;Journal of Personalized Medicine. 2021 Aug 31
• 18 citations
  The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.
  Daniel A. Rossignol, Richard E. Frye> ;Journal of Personalized Medicine. 2021 Aug 11
• 15 citations
  A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder.
  Daniel A. Rossignol, Richard E. Frye> ;Journal of Personalized Medicine. 2021 May 30
• 16 citations
  Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
  Richard E. Frye, Daniel A. Rossignol, Lawrence Scahill, Christopher J. McDougle, Harris S. Huberman, Edward V. Quadros> ;Seminars in Pediatric Neurology. 2020 Jun 25
• 80 citations
  Emerging biomarkers in autism spectrum disorder: a systematic review.
  Richard E. Frye, Sarah Vassall, Gurjot Kaur, Christina Lewis, Mohammand Karim, Daniel A. Rossignol> ;Annals of Translational Medicine. 2019 Nov 27
• 116 citations
  Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
  Shannon Rose, Dmitriy Niyazov, Daniel A. Rossignol, Michael J. Goldenthal, Stephen G. Kahler, Richard E. Frye> ;Molecular Diagnosis & Therapy. 2018 Oct 1
• 63 citations
  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes
  Richard E. Frye, Daniel A. Rossignol> ;Clinical Medicine Insights. Pediatrics. 2016 Jun 15
• 42 citations
  Melatonin in autism spectrum disorders.
  Daniel A. Rossignol, Richard E. Frye> ;Current Clinical Pharmacology. 2014 Oct 31
• 44 citations
  The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.
  Daniel A. Rossignol, Richard E. Frye> ;Frontiers in Pediatrics. 2014 Aug 22
• 53 citations
  Treatments for biomedical abnormalities associated with autism spectrum disorder.
  Richard E. Frye, Daniel A. Rossignol> ;Frontiers in Pediatrics. 2014 Jun 27
• 248 citations
  Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.
  Daniel A. Rossignol, Richard E. Frye> ;Frontiers in Physiology. 2014 Apr 22
• 290 citations
  Environmental toxicants and autism spectrum disorders: a systematic review
  Daniel A. Rossignol, S J Genuis, Richard E. Frye> ;Translational Psychiatry. 2014 Feb 11
• 1 citations
  My experience learning about autism.
  Daniel A. Rossignol> ;Global Advances in Health and Medicine. 2013 Nov 1
• 57 citations
  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.
  Richard E. Frye, Daniel A. Rossignol, Manuel F. Casanova, Gregory L. Brown, Victoria Martin, Stephen M. Edelson, Robert Coben, Jeffrey D. Lewine, John Slattery, Chryst...> ;Frontiers in Public Health. 2013 Sep 13
• 153 citations
  Cerebral folate receptor autoantibodies in autism spectrum disorder
  Richard E. Frye, Jeffrey M. Sequeira, Edward V. Quadros, S J James, Daniel A. Rossignol> ;Molecular Psychiatry. 2013 Mar 1
• 349 citations
  A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunctio...
  Daniel A. Rossignol, Richard E. Frye> ;Molecular Psychiatry. 2012 Apr 1
• 535 citations
  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
  Daniel A. Rossignol, Richard E. Frye> ;Molecular Psychiatry. 2012 Mar 1
• 23 citations
  Hyperbaric oxygen treatment in autism spectrum disorders
  Daniel A. Rossignol, James Jeffrey Bradstreet, Kyle Van Dyke, Cindy Schneider, Stuart H Freedenfeld, Nancy O’Hara, Stephanie Cave, Julie A Buckley, Elizabeth Mumper, R...> ;Medical Gas Research. 2012 Jun 15
• 3 citations
  Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy.
  Daniel A. Rossignol, Richard E. Frye> ;Journal of Autism and Developmental Disorders. 2012 Apr 1
• 28 citations
  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis
  Daniel A. Rossignol> ;Medical Gas Research. 2012 Mar 15
• 251 citations
  Melatonin in autism spectrum disorders: a systematic review and meta-analysis.
  Daniel A. Rossignol, Richard E. Frye> ;Developmental Medicine and Child Neurology. 2011 Sep 1
• Join now to see all